Singapore firm jumps as virus test kit approved for EU sale


An employee works at a front desk of the Singapore Exchange head office in Singapore in this April 22, 2015 file photo. Singapore Exchange's (SGX) bid to buy London's Baltic Exchange is aimed at burnishing its derivatives credentials among ship brokers and commodity merchants, fitting hand in glove with its efforts to develop Asian pricing benchmarks for bulk commodities. REUTERS/Edgar Su/Files

SINGAPORE: Shares of Biolidics Ltd. jumped as the Singapore-based medical device manufacturer said its rapid test kits for Covid-19 were approved for sale in the European Union.

The stock rose as much as 12% in early trading after the firm announced on Monday that it received confirmation for CE marking on Friday. CE marking is a notification process to authorities which enables companies to market and sell products in the EU.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Business News

Wall St set to open lower as Meta Platforms, economic data weigh
Al-’Aqar REIT aims to acquire yield-accretive properties from KPJ Healthcare
Samenta wants micro enterprises to be exempted from e-invoicing
Pantech seeks Main Market listing for subsidiaries via SPV
Inta Bina secures RM224.80mil contract for serviced apartment project
UMediC transfers to Main Market
Ringgit closes marginally higher against US dollar
AirAsia X mulls flying to Eastern Europe, London and Orlando
MKHOP posts RM16mil net profit in 2Q24
Gobind: Appointment of new DNB board members marks major milestone in 5G network restructuring

Others Also Read